Showing results (1621-1630 of 1,711) with videos related to
Sort By:
Pageof 172
JACC. Cardiovascular Imaging|March 7, 2023
Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel StatementThomas H Schindler, William F Fearon, Matthieu Pelletier-Galarneau, et al.JACC. Cardiovascular Interventions|January 14, 2026
IVUS, OCT, or Angiography as Guidance for PCI in Complex Coronary Artery Lesions: Network Meta-Analysis of Randomized Controlled TrialsPedro E P Carvalho, Vanio L J Antunes, Vinicius Bittar de Pontes, et al.Cardiology|May 29, 2026
C-Reactive Protein and Long-Term Risk of Death in Patients with Myocardial InfarctionJulie Borchsenius, Kristian H Kragholm, Deepak L Bhatt, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter valve-in-valve versus redo-surgical valve replacement for mitral bioprosthetic valve dysfunction: rationale and design of the SURVIV randomised trialDimytri A Siqueira, Alexandre A C Abizaid, Auristela A Ramos, et al.European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.JAMA Cardiology|June 1, 2022
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A ReviewBehnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, et al.European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.European Journal of Preventive Cardiology|February 9, 2026
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk scoreJoris Holtrop, Mari N Gynnild, Matthew Richards, et al.European Heart Journal|May 7, 2025
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statementStefano Romeo, Antonio Vidal-Puig, Mansoor Husain, et al.The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.Pageof 172